Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting
Linh‐Vi Le(World Health Organization Regional Office for the Western Pacific), Devin Razavi‐Shearer(University of London), Naoko Ishikawa(World Health Organization Regional Office for the Western Pacific), Polin Chan(World Health Organization Regional Office for the Western Pacific), Nabeel Mangadan Konath(World Health Organization Regional Office for South-East Asia), Homie Razavi(Center for Disease Analysis), Sarah Blach(Center for Disease Analysis), Mukta Sharma(Children's Mercy Hospital), Bharat Bhushan Rewari(National AIDS Control Organisation), Daniel Low‐Beer(World Health Organization)
Cited by 28
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|The Lancet. Gastroenterology & hepatology|2023|399